Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Kellum Kudos

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jul 26, 2022 12:12pm

244 Views

Post# 34851236

RE:RE:Kellum Kudos

The Sepsis campaign of today's release is not a reach out to investors.

It is a compliment to the Vincenza show where PMX is introduced to the medical community at large and nephrologists in general.

Beyond the obligatory requirement to inform investors, it is all about preparing doctors and clinicians for the PMX launch!!!

It's coming sooner than 99% of our 40 or less retail investors expect!

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December